The SToICAL Study - The Soft Tissue Injection of Corticosteroid And Local Anaesthetic Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Clinical Phase

PHASE3

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-26

Study Completion Date

2025-11-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Some hand conditions can be treated with a steroid injection. Some doctors mix the steroid with local anaesthetic in the hope that the patient will experience less pain after the injection. Some doctors do not do this. It is not known if adding local anaesthetic to the steroid improves patient's pain after the injection.

The overall aim of the study is to see whether using local anaesthetic in the steroid injection makes a difference to patients' pain. If the study shows that using local anaesthetic improves patients' pain then the investigators should continue using it. If not, the investigators should stop giving patients unnecessary medication, which would also save the NHS time and money.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pain With Trigger Finger Injection: A Comparison of Steroid Alone Versus Steroid/Lidocaine Mixture

NCT02421419

Trigger Finger Disorder

TERMINATED PHASE4

Treatment Efficacy of Local Anesthetic/Steroid Mixture Injection for Patients With Odynophonia

NCT05178485

Patients With a Diagnosis of Odynophonia

WITHDRAWN PHASE4

Corticosteroid Injection Verses High Energy Extracorporeal Shock Wave Therapy for Lateral Epicondylitis

NCT02613455

Lateral Epicondylitis Tennis Elbow

UNKNOWN PHASE4

TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone

NCT03028012

Myofascial Pain

TERMINATED PHASE4

Vibratory Anesthesia in Trigger Finger Injections

NCT05405452

Trigger Finger Pain Anesthesia, Local

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a single site, patient and assessor blinded, non-inferiority randomised control trial of patients with a clinical diagnosis of trigger finger, de Quervains tenosynovitis or carpal tunnel syndrome, treated with a corticosteroid injection co-administered with or without local anaesthetic.

The aim is to determine whether pain experienced during the 24 hours after a corticosteroid injection to the hand and wrist is no worse than (not inferior to) the pain experienced after a corticosteroid and local anaesthetic injection.

The primary outcome is to investigate whether there is a difference in pain VAS scores at 1-hour after a corticosteroid injection for trigger finger, de Quervains tenosynovitis or carpal tunnel syndrome co-administered with or without local anaesthetic. Secondary outcomes look at differences in pain VAS scores within the first 24-hours after the injection, at the time of the injection and enquires about effects on hand function.

Patients attending elective hand and wrist outpatient clinics at the University Hospitals Plymouth NHS Trust with a clinical diagnosis of trigger finger, de Quervains tenosynovitis and carpal tunnel syndrome will be screen for eligibility for recruitment.

All patients over the age 18 years old with a clinical diagnosis of trigger finger, de Quervains tenosynovitis or carpal tunnel syndrome and who are able to give written informed consent for treatment will be included. Patients will be excluded if they have had previous surgery or corticosteroid injection for the condition being treated at the site considered for injection. A previous corticosteroid injection elsewhere in the hand does not exclude a patient from the trial. Those who are pregnant, breast-feeding or who have a history of hypersensitivity to corticosteroid or local anaesthetic will be excluded.

The study will run for a 12-month period or until 100 patients have been recruited to the trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carpal Tunnel Syndrome De Quervains Tenosynovitis Trigger Finger

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Corticosteroid injection

Single injection of 1ml of triamcinolone (40mg/1ml)

Group Type EXPERIMENTAL

1ml of triamcinolone (40mg/1ml)

Intervention Type DRUG

Single injection of 1ml of triamcinolone (40mg/1ml)

Corticosteroid and local anaesthetic injection

Single injection of 1ml of triamcinolone (40mg/1ml) + 1ml 1% Lidocaine

Group Type ACTIVE_COMPARATOR

1ml of triamcinolone (40mg/1ml)

Intervention Type DRUG

Single injection of 1ml of triamcinolone (40mg/1ml)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

1ml of triamcinolone (40mg/1ml)

Single injection of 1ml of triamcinolone (40mg/1ml)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female ages \>/= 18 years
* A clinical diagnosis of trigger finger, de Quervains tenosynovitis or carpal tunnel syndrome made by a consultant physician.
* Treatment with corticosteroid injection is recommended by the doctor and agreed by the patient
* Patient is willing and able to give informed consent for participation in the study

Exclusion Criteria

* Previous surgery for the condition being treated at the desired location of injection
* Previous steroid injection for the condition being treated at the desired location of injection
* Clinical suspicion of local or systematic sepsis or infection
* History of hypersensitivity to the corticosteroid or local anaesthetic
* Pregnant or breast-feeding females
* Unable to understand and complete self-report questionnaires written in English

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes